Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services, announced on Wednesday its quarterly cash dividend.
The company has declared dividend of USD0.56 per share.
The dividend will be paid to shareholders of record at 20 January 2021 on 3 February 2021.
The company's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviours and improve health care management.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development